Model N Announces Date of Third Quarter Fiscal Year 2019 Financial Results

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), a leading provider of cloud revenue management solutions for life sciences and high tech companies, plans to announce financial results for the third quarter fiscal year 2019 after market close on Tuesday, August 6, 2019. The company also will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to review its financial results and business outlook.

The conference call can be accessed by dialing (877) 407-4018 from the United States or (201) 689-8471 internationally with reference to the company name and conference title. A live webcast and replay of the conference call can be accessed from the investor relations page of Model N’s website at investor.modeln.com. Following the completion of the call through 11:59 p.m. ET on August 13, 2019, a telephone replay will be available by dialing (844) 512-2921 from the United States or (412) 317-6671 internationally with recording access code 13692261.

About Model N

Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Driving mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives, our software helps companies know and grow their true top line and maximize every revenue moment at speed and scale. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Contacts

Investor Relations Contact:

ICR for Model N

Staci Mortenson, 650-610-4998

investorrelations@modeln.com

Media Contact:

pr@modeln.com

Staff

Recent Posts

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism

In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity…

1 hour ago

Introduction of Connected Care for Canadians Act

TORONTO, Feb. 4, 2026 /CNW/ - Canada Health Infoway (Infoway) welcomed today's introduction of Bill S-5, the…

10 hours ago

Introduction of Connected Care for Canadians Act

TORONTO, Feb. 4, 2026 /CNW/ - Canada Health Infoway (Infoway) welcomed today's introduction of Bill S-5, the…

10 hours ago

In HelloNation, Occupational Health Expert Kat Parmer of Cheyenne, WY, Shares a Guide for Effective Pre-Employment Screenings

CHEYENNE, Wyo., Feb. 4, 2026 /PRNewswire/ -- How can Wyoming employers ensure that new hires…

10 hours ago

In HelloNation, Occupational Health Expert Kat Parmer of Cheyenne, WY, Shares a Guide for Effective Pre-Employment Screenings

CHEYENNE, Wyo., Feb. 4, 2026 /PRNewswire/ -- How can Wyoming employers ensure that new hires…

10 hours ago

Candid Health Named to the 2026 New York Digital Health 100

DH100 recognizes the companies shaping the future of healthcare innovation in NY, spotlighting Candid's role…

10 hours ago